Commodity Channel Index
|Bid||2.4000 x 1400|
|Ask||0.0000 x 3100|
|Day's Range||2.6600 - 2.7900|
|52 Week Range||1.5000 - 4.5000|
|Beta (5Y Monthly)||2.53|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this article we will check out the progression of hedge fund sentiment towards Galectin Therapeutics Inc. (NASDAQ:GALT) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of Galectin Therapeutics Inc. (NASDAQ:GALT) based on that […]
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Endo (ENDP) beats on both sales and earnings in the second quarter of 2019. However, both metrics decline year over year due to weak generic business.